Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$67000.0.

  • Biodesix's Cash from Investing Activities rose 7657.34% to -$67000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 7871.15%. This contributed to the annual value of -$3.4 million for FY2024, which is 8508.37% up from last year.
  • Per Biodesix's latest filing, its Cash from Investing Activities stood at -$67000.0 for Q3 2025, which was up 7657.34% from -$95000.0 recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Cash from Investing Activities peaked at -$67000.0 during Q3 2025, and registered a low of -$7.7 million during Q1 2023.
  • For the 5-year period, Biodesix's Cash from Investing Activities averaged around -$1.7 million, with its median value being -$641000.0 (2021).
  • Per our database at Business Quant, Biodesix's Cash from Investing Activities crashed by 208920.45% in 2023 and then surged by 9645.73% in 2024.
  • Over the past 5 years, Biodesix's Cash from Investing Activities (Quarter) stood at -$641000.0 in 2021, then plummeted by 209.98% to -$2.0 million in 2022, then tumbled by 51.03% to -$3.0 million in 2023, then surged by 70.54% to -$884000.0 in 2024, then skyrocketed by 92.42% to -$67000.0 in 2025.
  • Its last three reported values are -$67000.0 in Q3 2025, -$95000.0 for Q2 2025, and -$137000.0 during Q1 2025.